# VYALEV
> **NDA216962** · New Drug Application · Sponsor: ABBVIE · Approved 2024-10-16
## Drug
- **FDA Application Number:** NDA216962
- **Application type:** New Drug Application
- **Brand name:** VYALEV
- **Generic name:** FOSCARBIDOPA/FOSLEVODOPA
- **Active ingredients:** FOSCARBIDOPA; FOSLEVODOPA
- **Dosage form:** SOLUTION
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** ABBVIE
- **Manufacturer:** AbbVie Inc.
- **First approval:** 2024-10-16
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216962)
---
*AI Analytics · CC0 1.0*